1. Home
  2. IDXX

as 12-18-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Nasdaq

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

Founded: 1983 Country:
United States
United States
Employees: N/A City: WESTBROOK
Market Cap: 35.5B IPO Year: 1991
Target Price: $539.63 AVG Volume (30 days): 618.1K
Analyst Decision: Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 10.36 EPS Growth: 5.57
52 Week Low/High: $398.50 - $583.39 Next Earning Date: 02-03-2025
Revenue: $3,844,817,000 Revenue Growth: 7.16%
Revenue Growth (this year): 8.03% Revenue Growth (next year): 6.83%

IDXX Daily Stock ML Predictions

Stock Insider Trading Activity of IDEXX Laboratories Inc. (IDXX)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Vandebroek Sophie V. IDXX Director Nov 27 '24 Sell $420.44 344 $144,629.64 905

Share on Social Networks: